MeMed
                     MeMed
Translating the complex signaling of the 
immune system into simple diagnostic 
insights.
We are applying machine learning and artificial intelligence to the 
complex signaling of the world's most accurate diagnostic system, 
the immune system.
Our AI-based diagnostics address key clinical and 
medical challenges in infectious diseases and 
inflammatory disorders.
MeMed BV is a pioneering test for distinguishing 
between bacterial and viral infections that relies on 
the most accurate detection system - the body's 
immune system.
MeMed BV aims to support physicians in making 
better informed antibiotic treatment decisions and 
tackling antimicrobial resistance - one of the 
biggest healthcare challenges of our time.
MeMed Key is a first of its kind immunoassay 
platform, that opens the way to measuring 
multiple proteins with central lab performance 
at the point-of-need.
Key will deliver MeMed BV test results in 15 
minutes.
Our technology and products have been developed 
and rigorously validated in large multinational clinical 
studies encompassing thousands of patients and 
published in high impact scientific and medical 
journals.
MeMed Co-Founder & CEO, Dr. Eran Eden presented 
at ECCMID 2021, with highlights from the Observer st
udy “A host assay comprising TRAIL, IP-10 and CRP 
can improve antibiotic treatment decisions for viral P
CR positive adults by accurately ruling out co-infectio
n”